Research Reports

Healthcare

icon
Home » Reports » Anti Malarial Drugs Market
Market Research Report

Anti-Malarial Drugs Market By Drug Type (Quinine, Chloroquine, Amodiaquine, Pyrimethamine, Proguanil, Sulfonamide, Mefloquine, Atovaquone, Primaquine, Artemisinin and derivatives, Halofantrine, Doxycycline, Clindamycin); By Application (Resistance, Prevention; & By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E- Commerce, Others)- Global Demand Analysis & Opportunity Outlook 2027

Published On : 01:18 AM, 19th September, 2018 REP-ID-914 Category: Healthcare

Anti-Malarial Drugs Market Overview

Anti-malarial drugs are the medicines used to prevent and treat malaria. They are used for prevention of infection in individuals who travel to malaria-endemic regions.  Malaria is the disease caused due to the parasite known as Plasmodium, which belongs to the group of Protozoans. The malaria disease occurs in the tropical, subtropical and temperate regions of the world. Efficient antimalarial therapy not only reduces the illness and mortality of malaria, but also decreases the peril of resistance to antimalarial drugs. The rising prevalence of the malarial disease globally is estimated to enhance the demand of anti-malarial drugs and push the global market.

Market Size & Forecast

The global anti-malarial drugs market is anticipated to record a significant CAGR over a forecast period. The increasing R&D activities for new drugs and new combinations of drugs, due to resistance by the parasites to the currently available drugs, are also expected to drive the global anti-malarial drugs market.

The efficiency of timely diagnosis and effective treatment are the primary technical factors of the global strategy to control malaria are highly dependent on the efficacy, safety, availability, affordability and acceptability of anti-malarial drugs. Efficient antimalarial therapy not only reduces the illness and mortality of malaria, but also decreases the peril of resistance to antimalarial drugs.

On the basis of regional platform, global anti-malarial drugs market and biopharmaceutical oral drug delivery market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

Anti-malarial drugs

North America is presently contributing the foremost shares to the global anti-malarial drugs market in terms of revenue and is expected to record a substantial CAGR over the forecast period. Europe is also contributing adequate shares to the market owing to the progressed medical facilities and accessibility of the anti-malarial drugs in the market. Availability of key players, better R&D facilities and better reimbursement policies are the factors driving the growth of this market.

Asia-Pacific is the most profitable market for the anti-malarial drugs due to the elevated incidence of the malarial diseases in the region and is expected to show a robust growth to the global anti-malarial drugs market. Middle East & Africa is at a budding stage of the global anti-malarial drugs market and is projected to register a decent growth of the market over a forecast period.

Market Segmentation

Our-in depth analysis of the global anti-malarial drugs market and biopharmaceutical oral drug delivery market includes the following segments:

By Drug Type

  • Quinine
  • Chloroquine
  • Amodiaquine
  • Pyrimethamine
  • Proguanil
  • Sulfonamide
  • Mefloquine
  • Atovaquone
  • Primaquine
  • Artemisinin and derivatives
  • Halofantrine
  • Doxycycline
  • Clindamycin

By Application

  • Resistance
  • Prevention

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • E- Commerce

By Region

Global anti-malarial drugs market and biopharmaceutical oral drug delivery market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Anti malarial drugs market share

Growth Drivers & Challenges

The rising occurrence of the malarial disease worldwide is anticipated to push the demand of the anti-malarial drugs and drive the global anti-malarial drugs market. Favorable government regulations, development of multi-drug resistance (MDR), and increase in innovation and R&D in terms of anti-malaria therapeutics is estimated to complement market growth.

The strong initiatives taken by the various state governments and regulatory bodies such as U.S. Food and Drug Administration (FDA) to decrease the frequency of malarial disease throughout the world, are also expected to fuel the demand for the anti-malarial drugs and has become one of the element that drives the global anti-malarial drugs market over the forecast period.

However, the probable side effects of the anti-malarial drugs such as vivid dreams, sleeplessness, mental clouding, vertigo and nervousness may impede the demand for the anti-Malarial drug and limit the growth of the global anti-malarial drugs market.

The accessibility of pure quality of drugs in the Southeast Asia and Saharan African countries leads to the inadequate treatment, which may pose a risk to the demand of the anti-malarial drugs and restrict the growth of the global anti-malarial drugs market over the forecast period.

Key Players

  • Pfizer
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • GlaxoSmithKline Plc.
  • Ranbaxy Laboratories
  • Ipca Laboratories Ltd.
  • Zydus Cadila
  • Merck KGaA
  • Novartis AG
  • Alvizia Health Care
  • Bayer AG
  • Roche Inc.

Scope & Context                                                 

Overview of the Parent Market

Analyst View

Segmentation

The global anti-malarial drugs market and biopharmaceutical oral drug delivery is segmented as follows:

  • By Drug Type Market Size & Y-O-Y Growth Analysis
  • By Application Market Size & Y-O-Y Growth Analysis
  • By Distribution Channel Type Market Size & Y-O-Y Growth Analysis
  • By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

key Answers

 

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2018 Research Nester. All rights reserved

Top